As part of its ongoing commitment to the nation's space program, NASA's medical leadership asked the Institute of Medicine (IOM) to review specific aspects of the scientific basis, policies, and procedures associated with the Longitudinal Study of Astronaut Health (LSAH). NASA created the LSAH in 1992 to address a variety of issues, including both the health of astronauts during space flight and the longer-term health issues that might be associated with space flight and flight training.
David E. Longnecker, Frederick J. Manning, and Melvin H. Worth, Jr., Editors, Committee on the Longitudinal Study of Astronaut Health
1 Front Matter; 2 Executive Summary; 3 1 Introduction; 4 2 Findings to Date; 5 3 Issues with Design and Implementation of the Current Longitudinal Study; 6 4 Recommendations for Changes in Study Design and Execution; 7 5 Recommendations for Changes in Health Care Policy; 8 References; 9 Appendix A: Biosketches of Committee and Staff; 10 Appendix B: Variables in the LSAH Database; 11 Appendix C: Health Lifestyle Questionnaire
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
National Research Council, Institute of Medicine, Aeronautics and Space Engineering Board, Space Studies Board, Board on Health Sciences Policy, Committee on Review of NASA's Bioastronautics Roadmap, Ricardo A. Molins, David E. Longnecker
Institute of Medicine, Board on Health Sciences Policy, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Andrew Pope, Peter Bouxsein, Frederick J. Manning, Kathi E. Hanna
Institute of Medicine, Board on Health Sciences Policy, Committee for Assessment of NIH Centers of Excellence Programs, Ronald Estabrook, Michael McGeary, Frederick J. Manning
Institute of Medicine, Board on Health Sciences Policy, Committee on Evaluation of the Metropolitan Medical Response Program, Lewis Goldfrank, Frederick J. Manning
Institute of Medicine, Board on Health Sciences Policy, Committee on Evaluation of the Metropolitan Medical Response System Program, Lewis Goldfrank, Frederick J. Manning